A meta-analysis showed that AD patients had lower levels of dopamine and dopamine receptors (DRD1 and DRD2) as compared to controls, which could be contributing to dysregulation of mood and emotional stability as well as memory dysfunction [91]. This evidence concerns the gene DRD2 and Alzheimer disease.